Pemetrexed-Erlotinib, Pemetrexed Alone, or Erlotinib Alone as Second-Line Treatment for East Asian and Non-East Asian Never-Smokers with Locally Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer: Exploratory Subgroup Analysis of a Phase II Trial

PURPOSE: This subgroup analysis of a phase II trial was conducted to assess possible ethnicity-based trends in efficacy and safety in East Asian (EA) and non-EA populations with nonsquamous non-small cell lung cancer (NSCLC). MATERIALS AND METHODS: Never-smoker patients (n=240) with locally advanced...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Dae Ho, Lee, Jung Shin, Wang, Jie, Hsia, Te-Chun, Wang, Xin, Kim, Jongseok, Orlando, Mauro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4614205/
https://www.ncbi.nlm.nih.gov/pubmed/25672577
http://dx.doi.org/10.4143/crt.2014.051

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4614205/
https://www.ncbi.nlm.nih.gov/pubmed/25672577
http://dx.doi.org/10.4143/crt.2014.051

Ejemplares similares